4.7 Review

The fallacy of the calcium-phosphorus product

Journal

KIDNEY INTERNATIONAL
Volume 72, Issue 7, Pages 792-796

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1038/sj.ki.5002412

Keywords

calcium; chronic kidney disease; vascular calcification; hyperphosphatemia; mineral metabolism

Funding

  1. NIDDK NIH HHS [DK069681] Funding Source: Medline

Ask authors/readers for more resources

Scattered through the practice of medicine are dogmas with little or no scientific basis. One of these is the product of the serum calcium and phosphorus concentrations, the so-called calcium-phosphorus product or Ca x P. The assumption that ectopic calcification will occur when the product of the serum calcium and phosphorus concentrations exceeds a particular threshold has become standard practice in nephrology even though there is little scientific basis. Experimental support is lacking, the chemistry underlying the use of the product is oversimplified and the concept that ectopic calcification is simply the result of supersaturation is biologically flawed. The evidence that the Ca x P is an independent risk factor for mortality and morbidity is also questionable. Although ectopic calcification can occur in many sites, this review will focus on vascular calcification, as it is the most common site and the site most likely to affect patient outcomes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available